Abstract
Gliomas in children differ from their adult counterparts by their distribution of histological grade, site of presentation and rate of malignant transformation. Although rare in the paediatric population, patients with high-grade gliomas have, for the most part, a comparably dismal clinical outcome to older patients with morphologically similar lesions. Molecular profiling data have begun to reveal the major genetic alterations underpinning these malignant tumours in children. Indeed, the accumulation of large datasets on adult high-grade glioma has revealed key biological differences between the adult and paediatric disease. Furthermore, subclassifications within the childhood age group can be made depending on age at diagnosis and tumour site. However, challenges remain on how to reconcile clinical data from adult patients to tailor novel treatment strategies specifically for paediatric patients.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Nature Reviews. Clinical Oncology |
| Vol/bind | 9 |
| Udgave nummer | 7 |
| Sider (fra-til) | 400-13 |
| Antal sider | 14 |
| DOI | |
| Status | Udgivet - jul. 2012 |
Emneord
- Adult
- Age Factors
- Brain Neoplasms
- Child
- Glioma
- Humans
- Prognosis